EX-23.01 3 ex23-01.htm CONSENT OF MAYER HOFFMAN MCCANN P.C.
 

Adamis Pharmaceuticals Corporation S-8

EXHIBIT 23.01

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 30, 2017, relating to the consolidated financial statements of Adamis Pharmaceuticals Corporation and Subsidiaries (the “Company”), which report appears in the annual report on Form 10-K of the Company for the year ended December 31, 2016, and includes an explanatory paragraph as to an uncertainty with respect to the Company’s ability to continue as a going concern.

 

/s/ Mayer Hoffman McCann P.C.    
MAYER HOFFMAN McCANN P.C.  

 

San Diego, California
June 23, 2017